Evidence map›Paper›PMID 33922969›Full record

ArticleGenes2021

Deletion of the Imprinted

Emily Angiolini, Ionel Sandovici, Philip M Coan, Graham J Burton, Colin P Sibley, Abigail L Fowden, Miguel Constância

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. PHLDA2 in cancer: From molecular mechanisms to therapeutic opportunities.The Journal of pharmacology and experimental therapeutics · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Emily AngioliniUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge CB2 0QQ, UK.
Ionel SandoviciUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge CB2 0QQ, UK.ORCID 0000-0001-5674-4269
Philip M CoanCentre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.ORCID 0000-0001-6158-380X
Graham J BurtonCentre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.ORCID 0000-0001-8677-4143
Colin P SibleyMaternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9WL, UK.ORCID 0000-0002-2713-0492
Abigail L FowdenCentre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.
Miguel ConstânciaUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge CB2 0QQ, UK.ORCID 0000-0002-8976-1679
University of Cambridge · GBBabraham Institute · GBManchester Academic Health Science Centre · GB

Funding

Biotechnology and Biological Sciences Research Council BB/B50118X/1Biotechnology and Biological Sciences Research Council BB/B50118X/2Biotechnology and Biological Sciences Research Council BB/F02293X/1
6 · The paper itself

Abstract

Genomic imprinting, an epigenetic phenomenon that causes the expression of a small set of genes in a parent-of-origin-specific manner, is thought to have co-evolved with placentation. Many imprinted genes are expressed in the placenta, where they play diverse roles related to development and nutrient supply function. However, only a small number of imprinted genes have been functionally tested for a role in nutrient transfer capacity in relation to the structural characteristics of the exchange labyrinthine zone. Here, we examine the transfer capacity in a mouse model deficient for the maternally expressed

Indexed as

Maternal-Fetal Exchange3-O-MethylglucoseAnimalsbeta-AlanineFemaleGene DeletionGenomic ImprintingInulinMannitolMiceMice, Inbred C57BLNuclear ProteinsPlacentaPregnancy2,2-dimethyl-beta-alanine3-O-Methylglucosebeta-AlanineInulinMannitolNuclear ProteinsTSSC3 proteinfetal growthgenomic imprintingpassive permeabilityPhlda2placenta

Identifiers

PMID33922969
PMCPMC8146920
OpenAlexW3158193086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.